Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Ephedrine: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
>Brack
started ephedrine page
 
>Khuntosaurusrex
Started overhaul
Line 4: Line 4:
{{headerpanel|{{proofread}}{{Approval}}}}
{{headerpanel|{{proofread}}{{Approval}}}}
{{SummarySheet}}
{{SummarySheet}}
{{SubstanceBox/Example}}
{{SubstanceBox
 
    <!-- Special Parameters -->
    |displayClasses={{{displayClasses|}}}
    |MaterialTable_MaxWidth=250px
    |MaterialTable_Title={{PAGENAME}}
 
    <!-- Modules -->
    |ModuleSource=false
    |ModuleCombination=false
    |ModuleStructure=true
    |ModuleNomenclature=true
    |ModuleClassMembership=true
    |ModuleROA=true
 
 
    <!-- Structure -->
    |MolecularStructureCaption=
    |SkeletalImageFile=File:Ephedrine.svg
    |SkeletalImageWidth=245px
    |3DImageFile=
    |3DImageWidth=
 
 
    <!-- Nomenclature -->
    |NameCommon=Ephedrine, Ephedra
    |NameSubstitution=(1R,2S)-2-(methylamino)-1-phenylpropan-1-ol
    |NameSystematic=
 
    <!-- Class Membership -->
    |EffectClass=[[psychoactive class::Stimulant]]
    |ChemicalClass=[[chemical class::Phenethylamine]]
 
    <!-- Dosage/Duration per ROA -->
 
    |OralROA=true
    |OralROA_Collapsed=false
    |OralROA_Bioavailability=
    |OralROA_Caption=
    |OralROA_Microdose=
    |OralROA_Threshold=[[1.25 - 5::x]] - [5] [[Oral dose units::mg]]
    |OralROA_Light=[[Oral min light dose::x1]] - [[Oral max light dose::x2]] mg
    |OralROA_Common=[[Oral min common dose::x1]] - [[Oral max common dose::x2]] mg
    |OralROA_Strong=[[Oral min strong dose::x1]] - [[Oral max strong dose::x2]] mg
    |OralROA_Heavy=[[Oral heavy dose::x]] mg +
    |OralROA_TimelineFile=
    |OralROA_TimelineWidth=
    |OralROA_Duration=[[Oral min total time::x1]] - [[Oral max total time::x2]] [[Oral total time units::hours]]
    |OralROA_Onset=[[Oral min onset time::x1]] - [[Oral max onset time::x2]] [[Oral onset time units::minutes]]
    |OralROA_Comeup=[[Oral min comeup time::x1]] - [[Oral max comeup time::x2]] [[Oral comeup time units::minutes]]
    |OralROA_Peak=[[Oral min peak time::x1]] - [[Oral max peak time::x2]] [[Oral peak time units::hours]]
    |OralROA_Offset=[[Oral min offset time::x1]] - [[Oral max offset time::x2]] [[Oral offset time units::hours]]
    |OralROA_Aftereffects=[[Oral min afterglow time::x1]] - [[Oral max afterglow time::x2]] [[Oral afterglow time units::hours]]
 
 
    |IntravenousROA=false
    |IntravenousROA_Collapsed=true
}}
 
 
Ephedrine is a sympathomimetic amine commonly used as a stimulant, concentration aid, decongestant, appetite suppressant, and to treat hypotension associated with anaesthesia.
Ephedrine is a sympathomimetic amine commonly used as a stimulant, concentration aid, decongestant, appetite suppressant, and to treat hypotension associated with anaesthesia.


Ephedrine is similar in molecular structure to the well-known drugs phenylpropanolamine and methamphetamine, as well as to the important neurotransmitter epinephrine (adrenaline).
Ephedrine is similar in molecular structure to the well-known drugs phenylpropanolamine and methamphetamine, as well as to the important neurotransmitter epinephrine (adrenaline). It is a substituted amphetamine.
 
<!-- Please ensure that any new substance articles are first published in the 'Talk' namespace. For example, a new article on XYZ substance should have the title "Talk: XYZ" instead of "XYZ". Once the submitted article has been reviewed and determined to meet the guidelines and standards, it will be published by a staff member. -->
<!-- Please ensure that any new substance articles are first published in the 'Talk' namespace. For example, a new article on XYZ substance should have the title "Talk: XYZ" instead of "XYZ". Once the submitted article has been reviewed and determined to meet the guidelines and standards, it will be published by a staff member. -->


Line 19: Line 80:
==Pharmacology==
==Pharmacology==
{{pharmacology}}
{{pharmacology}}
Ephedrine acts as a NDRA ([[norepinephrine]]-[[dopamine]] releasing agent)
Ephedrine primary mechanism of action is through increasing catecholamine activity at alpha and beta adrenergic receptors. It also acts as a NDRA ([[norepinephrine]]-[[dopamine]] releasing agent).
==Subjective effects==
==Subjective effects==
{{EffectStub}}
{{EffectStub}}
Line 93: Line 154:
*'''[[Effect::Multisensory effect2]]'''  
*'''[[Effect::Multisensory effect2]]'''  


}}
{{effects/transpersonal|
If applicable, a brief paragraph summary of the substance's transpersonal effects may be included here.
You may select from a list of transpersonal effects to add below [[Subjective effect index#Transpersonal effects|here]].
*'''[[Effect::Transpersonal effect1]]'''
*'''[[Effect::Transpersonal effect2]]'''
}}
}}


===Experience reports===
===Experience reports===

Revision as of 12:01, 14 August 2018


Template:Proofread

This page has not been fully approved by the PsychonautWiki administrators.

It may contain incorrect information, particularly with respect to dosage, duration, subjective effects, toxicity and other risks. It may also not meet PW style and grammar standards.

Summary sheet: Ephedrine
Ephedrine
Chemical Nomenclature
Common names Ephedrine, Ephedra
Substitutive name (1R,2S)-2-(methylamino)-1-phenylpropan-1-ol
Class Membership
Psychoactive class Stimulant
Chemical class Phenethylamine
Routes of Administration

WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.



Oral
Dosage
Threshold Using "1.25 - 5" as property chain is not permitted during the annotation process. - [5] mg
Light x1"x" can not be assigned to a declared number type with value 1. - x2"x" can not be assigned to a declared number type with value 2. mg
Common x1"x" can not be assigned to a declared number type with value 1. - x2"x" can not be assigned to a declared number type with value 2. mg
Strong x1"x" can not be assigned to a declared number type with value 1. - x2"x" can not be assigned to a declared number type with value 2. mg
Heavy x"x" is not a number. mg +
Duration
Total x1"x" can not be assigned to a declared number type with value 1. - x2"x" can not be assigned to a declared number type with value 2. hours
Onset x1"x" can not be assigned to a declared number type with value 1. - x2"x" can not be assigned to a declared number type with value 2. minutes
Come up x1"x" can not be assigned to a declared number type with value 1. - x2"x" can not be assigned to a declared number type with value 2. minutes
Peak x1"x" can not be assigned to a declared number type with value 1. - x2"x" can not be assigned to a declared number type with value 2. hours
Offset x1"x" can not be assigned to a declared number type with value 1. - x2"x" can not be assigned to a declared number type with value 2. hours
After effects x1"x" can not be assigned to a declared number type with value 1. - x2"x" can not be assigned to a declared number type with value 2. hours









DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.

Interactions


Ephedrine is a sympathomimetic amine commonly used as a stimulant, concentration aid, decongestant, appetite suppressant, and to treat hypotension associated with anaesthesia.

Ephedrine is similar in molecular structure to the well-known drugs phenylpropanolamine and methamphetamine, as well as to the important neurotransmitter epinephrine (adrenaline). It is a substituted amphetamine.


History and culture

This History and culture section is a stub.

As a result, it may contain incomplete or wrong information. You can help by expanding it.

Chemistry

This chemistry section is incomplete.

You can help by adding to it.

Pharmacology

This pharmacology section is incomplete.

You can help by adding to it.

Ephedrine primary mechanism of action is through increasing catecholamine activity at alpha and beta adrenergic receptors. It also acts as a NDRA (norepinephrine-dopamine releasing agent).

Subjective effects

This subjective effects section is a stub.

As such, it is still in progress and may contain incomplete or wrong information.

You can help by expanding or correcting it.

Disclaimer: The effects listed below cite the Subjective Effect Index (SEI), an open research literature based on anecdotal user reports and the personal analyses of PsychonautWiki contributors. As a result, they should be viewed with a healthy degree of skepticism.

It is also worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. Likewise, adverse effects become increasingly likely with higher doses and may include addiction, severe injury, or death ☠.

{{effects/base

|

Physical effects

Visual effects

|

Cognitive effects

Auditory effects

{{effects/multisensory| If applicable, a brief paragraph summary of the substance's multisensory effects may be included here.

You may select from a list of multisensory effects to add below here.


Experience reports

There are currently 0 experience reports which describe the effects of this substance in our experience index.

Additional experience reports can be found here:

Toxicity and harm potential

This toxicity and harm potential section is a stub.

As a result, it may contain incomplete or even dangerously wrong information! You can help by expanding upon or correcting it.
Note: Always conduct independent research and use harm reduction practices if using this substance.

It is strongly recommended that one use harm reduction practices when using this substance.

Lethal dosage

Tolerance and addiction potential

Ephedrine has a similar addiction potential to other common stimulants such as dextroamphetamine

Dangerous interactions

This dangerous interactions section is a stub.

As such, it may contain incomplete or invalid information. You can help by expanding upon or correcting it.

Warning: Many psychoactive substances that are reasonably safe to use on their own can suddenly become dangerous and even life-threatening when combined with certain other substances. The following list provides some known dangerous interactions (although it is not guaranteed to include all of them).

Always conduct independent research (e.g. Google, DuckDuckGo, PubMed) to ensure that a combination of two or more substances is safe to consume. Some of the listed interactions have been sourced from TripSit.

This legality section is a stub.

As such, it may contain incomplete or wrong information. You can help by expanding it.

  • Canada - Ephedrine can be sold for breathing purposes in 8 milligram doses OTC.
  • United states - Ephedrine is heavily regulated due to production of meth using ephedrine.

See also

(List along order below)

Literature

  • APA formatted reference

Please see the citation formatting guide if you need assistance properly formatting citations.

References